Janus Henderson Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.4M | Sell |
|
|||||
|
2025
Q2 | $15.8M | Sell |
|
|||||
|
2025
Q1 | $28M | Sell |
|
|||||
|
2024
Q4 | $32M | Sell |
|
|||||
|
2024
Q3 | $67.7M | Sell |
|
|||||
|
2024
Q2 | $131M | Sell |
|
|||||
|
2024
Q1 | $163M | Buy |
|
|||||
|
2023
Q4 | $163M | Sell |
|
|||||
|
2023
Q3 | $182M | Buy |
|
|||||
|
2023
Q2 | $187M | Buy |
|
|||||
|
2023
Q1 | $151M | Sell |
|
|||||
|
2022
Q4 | $167M | Sell |
|
|||||
|
2022
Q3 | $309M | Buy |
|
|||||
|
2022
Q2 | $180M | Buy |
|
|||||
|
2022
Q1 | $148M | Buy |
|
|||||
|
2021
Q4 | $114M | Buy |
|
|||||
|
2021
Q3 | $67.4M | Buy |
|
|||||
|
2021
Q2 | $48.1M | Sell |
|
|||||
|
2021
Q1 | $88.8M | Sell |
|
|||||
|
2020
Q4 | $260M | Sell |
|
|||||
|
2020
Q3 | $199M | Buy |
|
|||||
|
2020
Q2 | $178M | Buy |
|
|||||
|
2020
Q1 | $107M | Buy |
|
|||||
|
2019
Q4 | $105M | Sell |
|
|||||
|
2019
Q3 | $87.8M | Buy |
|
|||||
|
2019
Q2 | $136M | Sell |
|
|||||
|
2019
Q1 | $150M | Sell |
|
|||||
|
2018
Q4 | $106M | Buy |
|
|||||
|
2018
Q3 | $106M | Buy |
|
|||||
|
2018
Q2 | $128M | Sell |
|
|||||
|
2018
Q1 | $129M | Buy |
|
|||||
|
2017
Q4 | $114M | Buy |
|
|||||
|
2017
Q3 | $112M | Buy |
|
|||||
|
2017
Q2 | $70.8M | Buy |
|